Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS 2 for tumor-targeted photoimmunotherapy in bladder cancer
Nanoscale · 2025
DOI: 10.1039/d5nr00374a ↗Kurz gefasst
Fachartikel in der Zeitschrift Nanoscale, 2025. Verfasst von Andrew E-Y Chuang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Biomedical Materials and Tissue Engineering, International Ph.D. Program in Biomedical Engineering, College of Biomedical Engin…. Hauptthemen laut MEDLINE: Urinary Bladder Neoplasms, Molybdenum, Extracellular Vesicles, Disulfides. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Taipei Medical University.
Abstract (Originalsprache)
M1 macrophage-derived EVs engineered with MoS 2 enable tumor-targeted photothermal-immunotherapy, suppressing bladder cancer via potential CD8 + T-cell activation, PD-L1 reduction, and ROS generation under NIR irradiation. Created in BioRender. Chuang, A. (2025) https://BioRender.com/ct5w2pa.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Biomedical Materials and Tissue Engineering, International Ph.D. Program in Biomedical Engineering, College of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan.
- Cell Physiology and Molecular Image Research Center, Taipei Medical University-Wan Fang Hospital, Taipei 11696, Taiwan.
- Precision Medicine and Translational Cancer Research Center, Taipei Medical University Hospital, Taipei 11031, Taiwan.
- School of Biomedical Engineering, Taipei Medical University, New Taipei City, Taiwan.
- Department of Urology, School of Medicine, College of Medicine, Taipei Medical University, Taipei 11031, Taiwan. mexxliu@tmu.edu.tw.
- TMU Research Center of Urology and Kidney, Taipei Medical University, Taipei 11031, Taiwan.
Förderung
- Taipei Medical University
Zitieren
APA
Chuang, A. E., Tao, Y. K., Fan, Y. J., Chiu, H. J., Rethi, L., & Liu, C. H. (2025). Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS 2 for tumor-targeted photoimmunotherapy in bladder cancer. Nanoscale. https://doi.org/10.1039/d5nr00374a
Vancouver
Chuang AE, Tao YK, Fan YJ, Chiu HJ, Rethi L, Liu CH. Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS 2 for tumor-targeted photoimmunotherapy in bladder cancer. Nanoscale. 2025. doi:10.1039/d5nr00374a
BibTeX
@article{Chuang2025,
author = {Chuang, Andrew E-Y and Tao, Yu-Kuang and Fan, Yu-Jui and Chiu, Hung-Jui and Rethi, Lekshmi and Liu, Chia-Hung},
title = {Synergistic nanoplatform of M1 macrophage-derived extracellular vesicles and MoS 2 for tumor-targeted photoimmunotherapy in bladder cancer},
journal = {Nanoscale},
year = {2025},
doi = {10.1039/d5nr00374a}
}
EUVIMED